1. Chris skills & experiences
Seasoned professional with 20 years experience in pharmaceutical
companies, which twelve years in major Top 10, Chris has acquired
Global experience at the headquarter of US company for more than 5
years leading a strategic role as Head of Global Pricing & Market
Access for a portfolio composed by marketed brands and new
products in oncology, a universally acknowledged critical sector for
the future growth of pharmaceutical companies.
In his previous roles, Chris scope of responsibility did include the
management of Corporate Affairs, Regulatory Affairs, Medical Affairs,
Legal Affairs, Public Relations, Crisis Management while continuing to
build close-knit relationship with government bodies and trade
associations to achieve and maintain optimal market access for
patients.
Chris leadership skills include the management of small to mid-sized
teams and the development of broad and complex network across
functions and geographies, with the ability to speak 4 languages and
easily evolve in multi cultural environment.

2. Global & Local Success Stories highlighting the
needs of tailored solutions by countries
Geography Solutions developed
• Increasing access team expertise implementing a set of Contracting Options (or patient access schemes)
• Value Benchmark Tool to assess the value of a brand versus the competition taking into account internal and
external payers value drivers
• Reinforcing interaction between KAMs and SRs in oncology with Sales Reps Escalation Process
• Mapping new payers influencers together with reinforcing the cross-geographical & cross-functional interaction
with a Payers Influencers Networking Project
• Identifying key affiliate issues by countries and plotting them according their impact versus effort needed for the
oncology environment shaping team with an Issue Prioritization Matrix
• Building of an efficient business driven committee able to test-proof strategy or answer complex strategic
questions with an Oncology Payers Advisory Committee (OPAC)
• Cost-effectiveness and budget impact models designed to anticipate payers requests
B2B tool providing an analysis for products listed on onerous drugs list, helping Hospital Pharmacists to monitor
the prescriptions and overview the medical activity in their own hospital, while managing their budget and growth
of onerous drugs list.
B2B tool breaking down the acquisition costs versus preparation and invoicing costs for Hospital Pharmacist,
helping them to understand the difference in net margins for in- respectively out-patients using branded or generic
treatments.
Partnership with Regional Governmental Institutions in the context of programs oriented to improve the overall
efficiency of Public Health Services benefiting the patients. Sponsoring of a project aimed to design a “clinical
governance” model for Southern Regions to lower the migration index, reducing time from diagnosis to treatment
and increasing the number of correct and complete diagnosis.
Development of 24/7 call center to answer any hospital questions, increased networking and personal relationship
with hospital pharmacists through B2B team

3. Key steps to ground and improve any
value proposition
Increasing Value Proposition for Payers
Patient Access Scheme
Commercial in confidence
rebates
Local service library
Leveraging Clinical Data Package
Clinical Trial
Design
Incremental OS
Targeted
population
Biomarker
strategy
Upfront Sub-
group restriction
Pro-actively shaping the environment
Unmet medical needs TL’s endorsement Policy